Health Level 7, an Ann Arbor, Mich.-based not-for-profit organization that develops international standards for the electronic healthcare information industry, named Charles Jaffe, M.D., as its first chief executive officer, effective Feb. 28. Jaffe, who has served on HL7's board for 14 years, is senior global strategist for Intel Corp.’s Digital Health Group.Jaffe's appointment is an "in-kind supported" position for the volunteer-staffed HL7, meaning Intel will continue to pay his salary even as he works full time for HL7. Jaffe previously served as vice president of life sciences for San Diego-based SAIC and director of medical infomatics for AstraZeneca Pharmaceuticals. As CEO he will serve as "global ambassador" and HL7 industry spokesman, according to a news release. "Dr. Jaffe's extensive experience in the healthcare IT industry will help him lead HL7 in the development of critical healthcare IT standards in the U.S. and allow us to work more closely with our numerous affiliates worldwide," said HL7 Chairman Chuck Meyer. "We look forward to his strategic leadership continuing the momentum that HL7 has achieved in healthcare IT standards development during the past 20 years." HL7 announced the appointment at the Healthcare Information and Management Systems Society meeting in New Orleans. The 2,400-member HL7, which was founded in 1987, is sponsored by numerous software, healthcare information firms and federal agencies including Microsoft Corp., Intel Corp., Pfizer, Eli Lilly & Co., Quest Diagnostics, Kaiser Permanente, Boston Scientific Corp. and the U.S. Food and Drug Administration, Defense Department and Centers for Disease Control and Prevention. HL7 has established affiliates on five continents.